Nogent, Wednesday, November 8, 2023
In a strategic move designed to reinforce its status as a global partner in the supply of surgical instruments, Oury Medical is delighted to announce the acquisitions of Metal Global Concept (MGC) and of Imprint Medical. These acquisitions follow that of SMAO last December and reinforce the expansion strategy of the Oury Medical group orchestrated by SPE Capital since its investment in October 2022.
Oury Medical's ambition is to support its orthopedic customers from the design stage right through to mass production, with tailored, innovative solutions for all surgical instrumentation needs.
MGC Acquisition
For over 40 years, MGC has been supporting its customers in its core expertise of precision sheet metal work for the medical sector, as well as in the aerospace and paramedical segments.
As of 2018, with the support of a new Management team from the medical sector and its technical expertise in the production of metal housings, MGC is developing a complete range of containers for the medical, dental and veterinary segments. These top-quality products are immediately found on major global markets such as the USA and Japan.
With this in mind, the acquisition of MGC represents a crucial step in the construction of the Oury Medical Group. By adding containers to its product range, Oury Medical intends to position itself as the preferred partner for surgical instrumentation.
Imprint Medical Acquisition
Imprint Medical is a Lyon-based company with recognized expertise in the research and development of surgical implants and instruments. While retaining its independence, Imprint Medical will now be able to draw on the production and prototyping capabilities of the Oury Medical group to better serve its customers.
For Oury Medical, this acquisition means the creation of a fully-fledged R&D department, offering its customers new opportunities for collaboration and co-development from the very first sketches of a new design.
These acquisitions fit in perfectly with SPE Capital France and Tioopo Capital's strategy of creating value for their portfolio of SMEs by bringing: i) operational transformation, ii) synergistic build-ups to improve positioning in the value chain and customer offering, and iii) an international dimension.
Executive Perspective
Christian Oury, President of Oury Medical, comments: "These acquisitions demonstrate our commitment to being the complete solutions provider in the surgical instruments field, right from the design phase of new surgical techniques and associated instrumentation thanks to Imprint Medical R&D capabilities. By integrating MGC's innovative portfolio into our own, we are not only expanding our product range, but also raising the level of service and quality offered to our customers.
Georges-Alexandre Ancenys, SPE Capital France, comments: « As previously announced, following the acquisition of SMAO, we are delighted to continue supporting the development of Oury Medical with these new strategic acquisitions that enable the group to better meet the needs of its customers, offering them a complete solution from engineering to the complete instrument box. We are delighted and honored to join forces with MGC, Imprint Medical and all its employees to write this new page in Oury Medical Group's history.
These three acquisitions, just one year after we completed our investment in Oury-Guyé, closes a first cycle of acquisitions that gives Oury Medical the means to achieve its ambitions, and provides new opportunities for the Group's employees to develop and attract new talents. »
About Oury Medical
Oury Medical is a century-old company in medical devices, a player in the French Fab and labeled Entreprise du Patrimoine Vivant Français (E.P.V.). Founded in 1909 in Nogent, Haute-Marne, and strengthened by the Villiers-le Sec site (SMAO), Oury Medical has established its position in the development and manufacture of orthopedic instrumentation and ancillary equipment. Oury Medical's customers include some of the largest orthopedic groups in France and abroad.
About Metal Global Concept
MGC has been based in Grenoble for over 40 years. MGC supports its customers in its core expertise of precision sheet metal work. As of 2018, MGC is developing an industrial tool and organization focused on the development of containers for the medical segment.
About Imprint Medical
Imprint Medical is a company involved in the development of implants and instruments for the spine and orthopedics in general, having developed in-depth expertise in additive manufacturing in particular.
About SPE Capital
SPE France, co-founded and managed by Georges-Alexandre Ancenys and André Wagner, aims to invest in French SMEs with strong potential for transformation and growth. The investment team applies its know-how to help SMEs reach their full potential.
This support focuses on three main areas:
I) Operational transformation
II) Synergetic build-ups to improve value chain positioning and strengthen product ranges
III) Activating international growth levers
SPE France is an initiative of SPE Capital, an independent investment company with USD 500m AUM. It operates in France in the small-cap segment and in Africa in the mid-cap segment.